From Big Data to Precision Medicine

  title={From Big Data to Precision Medicine},
  author={Tim Hulsen and Saumya Shekhar Jamuar and Alan R. Moody and Jason Hansen Karnes and Orsolya Gy{\"o}ngyi Varga and Stine Hedensted and Roberto Spreafico and David A. Hafler and Eoin F. McKinney},
  journal={Frontiers in Medicine},
For over a decade the term “Big data” has been used to describe the rapid increase in volume, variety and velocity of information available, not just in medical research but in almost every aspect of our lives. As scientists, we now have the capacity to rapidly generate, store and analyse data that, only a few years ago, would have taken many years to compile. However, “Big data” no longer means what it once did. The term has expanded and now refers not to just large data volume, but to our… 

Figures and Tables from this paper

New Paradigm in Healthcare Industry Using Big Data Analytics
The ways in which big data can be used and the tools for analyzing big data are discussed, which aims to provide innovations that optimize patient care and generate value for healthcare institutions with improvements in medicine, infrastructure and funding.
Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation
The advances and challenges in big data, the use of EHRs and AI, and the flourishing of artificial intelligence are discussed, with great emphasis on the usage of nephrology and transplantation.
Innovations in Genomics and Big Data Analytics for Personalized Medicine and Health Care: A Review
This work reviewed and highlighted the significance of big data analytics for personalized medicine and health care by focusing mostly on machine learning perspectives on personalized medicine, genomic data models with respect to personalized Medicine, the application of data mining algorithms for personalized Medicine as well as the challenges the authors are facing right now in big data Analytics.
Power of big data to improve patient care in gastroenterology
There is great potential power in patient-level linkage of datasets to help quantify inequalities, identify best practice and improve patient outcomes, and the importance of engaging with patients to enable them to understand their data usage as fully as they wish.
Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine
Biobanking in the era of big data contribute to the development of predictive, preventive, and personalised medicine, for every patient providing the right treatment at the right time.
Knowledge Discovery Based on Data Analytics and Visualization Supporting Precision Medicine
  • Veska Gancheva
  • Computer Science
    2020 International Conference on Mathematics and Computers in Science and Engineering (MACISE)
  • 2020
A comprehensive system for precision medicine, which covers all phases of data discovery, data integration, data preprocessing, building models, data storage, data analysis and visualization can be very useful to scientists in support of precision medicine.
Imprecise Data and Their Impact on Translational Research in Medicine
As precision medicine remains subject to a substantial amount of data imprecision and lack of translational impact, a revision of methodological inference approaches is needed, which crucially deal with the assimilation of data features dynamically interconnected.


Big Data and Machine Learning in Health Care.
To understand the degree to which a predictive or diagnostic algorithm can be said to be an instance of machine learning requires understanding how much of its structure or parameters were predetermined by humans.
Big data from electronic health records for early and late translational cardiovascular research: challenges and potential
The challenges and potential of big data are critically reviewed, for the first time, across early and late stages of translational cardiovascular disease research to improve understanding of disease causation and classification relevant for early translation and to contribute actionable analytics to improve health and healthcare.
Core services: Reward bioinformaticians
The scientific community has failed to craft attractive career paths for those who do the analyses it increasingly requires, and institutions and funding bodies must carve out a viable place for bioinformaticians who focus on collaborations, and reward them for their abilities to navigate the myriad demands of multidisciplinary projects.
The next generation of precision medicine: observational studies, electronic health records, biobanks and continuous monitoring.
This article explores the limitations of traditional study designs and proposes that harnessing electronic health records and mobile device biometrics coupled to longitudinal data may prove to be a solution to many of these problems by capturing a 'real world' phenotype.
Alternative models for sharing confidential biomedical data
An alternative model that allows the protection of confidential data through a process the authors term ‘model to data’ (MTD), which has been successfully demonstrated in crowdsourced competitions and represents a promising alternative for increasing the use of data that cannot—or will not—be more broadly shared.
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine.
Future efforts that integrate broad, robust collection of phenotype data with purpose-collected research data in combination with a greater understanding of EHR data will create a rich resource for increasingly more efficient and detailed genome-phenome analysis to usher in new discoveries in precision medicine.
An epidemiological perspective of personalized medicine: the Estonian experience
The Estonian Biobank and several other biobanks established over a decade ago are now starting to yield valuable longitudinal follow‐up data for large numbers of individuals, and the combination of susceptibility alleles into polygenic risk scores has improved risk prediction of cardiovascular disease, breast cancer and severalother diseases.
The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across species
The Monarch Initiative is an international consortium dedicated to providing computational tools that leverage a computational representation of phenotypic data for genotype-phenotype analysis, genomic diagnostics, and precision medicine on the basis of a large-scale platform of multimodal data that is deeply integrated across species and covering broad areas of disease.
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
The evolution, accomplishments, opportunities, and challenges of the network are described, from its inception as a five- group consortium focused on genotype–phenotype associations for genomic discovery to its current form as a nine-group consortium pivoting toward the implementation of genomic medicine.
The IGNITE network: a model for genomic medicine implementation and research
The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework.